Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study Evaluating Safety and Feasibility of Hematopoietic Stem Cell Gene Transfer That Targets Factor VIII Delivery From Platelets for Patients With Hemophilia A

NCT03818763 is registered in ClinicalTrials.gov with Medical College of Wisconsin as lead sponsor.

NCT NCT03818763
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03818763 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study Evaluating Safety and Feasibility of Hematopoietic Stem Cell Gene Transfer That Targets Factor VIII Delivery From Platelets for Patients With Hemophilia A
Lead sponsor
Medical College of Wisconsin
Phase
Phase 1
Overall status
Active, not recruiting
Start date
April 29, 2020
Completion date
May 1, 2033
Enrollment
5 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia a